Also, mean resistances of both samples are measured and calculated to be 84.3 ± 10.2 Ω for multi and 117.8 ± 8.7 Ω for single.
In order to extract the values of R in the two different regimes, current voltage (IV) curves for both samples are measured at various temperatures as shown in Figure 5a,b.
PCO2 in both samples was measured using a blood gas analyzer (AVL 945; AVL List GMBH, Gratz, Austria).
Urine was 10 fold diluted, feces were made soluble by Solvable® at 50°C and the fluorescence of both samples was measured by spectrofluorometry (PerkinElmer LS50B, Courtaboeuf, France) using a 350 nm excitation wavelength.
The topography of both samples was measured in the initial state at room temperature, after heating to 80 °C and after cooling again to room temperature using white light interferometry (ZygoNewView 5000, Zygo, USA) and inverse optical microscopy (Olympus PMG3, Olympus Corporation, Japan).
pH, EC, TDS and DO of both irradiated and raw samples were measured using portable multiparameter (Model no-sension™ 156, Supplier-Hach Company USA, 2000) within half an hour of the collection of sample.
11 Nonenriched Sn-β samples were measured on both a Varian VNMRS spectrometer, and a Bruker Avance III HD spectrometer with comparable performances.
Aflibercept was collected from the syringes and both undiluted and diluted (1 10) samples were measured using a DeNovix DS-11+ Spectrophotometer.
The stiffness and strength of both unstabilised and stabilised cylindrical samples were measured, under different humidity conditions, by means of unconfined compression tests.
The P2 samples were measured both in solution and as a dried film, and the peptide in the presence and absence of different membrane-mimicking compounds.
